http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103027895-B
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a1e96f9c1e753727fc5529a6b974143b |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4422 |
filingDate | 2012-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2015-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4309cb3ee1c63f56ad6c052d3e4d910 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd0b5fdd3b82835e770a790219c9625e |
publicationDate | 2015-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-103027895-B |
titleOfInvention | Sugar-free cilnidipine dry-blend suspension and preparation method thereof |
abstract | The invention relates to the technical field of medicine, belongs to a chemical medicine for treating human diseases and a preparation method thereof, and particularly relates to a sugar-free cilnidipine dry-blend suspension and a preparation method thereof. The sugar-free cilnidipine dry-blend suspension is prepared from the following components in percentage by weight: 10% of cilnidipine, 20% of hydroxypropyl cellulose sodium, 25% of xanthan gum, 15% of sodium lauryl sulfate and 30% of fruit-flavor essence. The preparation method comprises the following steps: respectively drying and pulverizing cilnidipine, hydroxypropyl cellulose sodium, xanthan gum, sodium lauryl sulfate and fruit-flavor essence, and passing through an 80-mesh screen; evenly mixing the dried and pulverized medicinal powder by an equivalent incremental method, detecting an intermediate, packaging, carrying out complete inspection, and warehousing to obtain the sugar-free cilnidipine dry-blend suspension. The sugar-free cilnidipine dry-blend suspension is convenient to take, has high bioavailability, fully displays the function of cilnidipine on treating hypertension, and can be taken by diabetics. |
priorityDate | 2011-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 39.